Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fimbriae type 2 and type 3 are classified as short, filamentous, non-flagellar surface appendages composed of the protein pilin, arranged helically to form slender, bristle-like tubes emerging from the bacterial cell membrane[1][3][5][6]. Type 3 fimbriae are particularly prominent in Klebsiella pneumoniae and are distinguished by their structural parameters (helix-like structure, average pitch ~4.1 nm), their role in attachment to host epithelium, and as a virulence factor essential for biofilm formation and infection in the respiratory and urinary tracts[1][4]. The primary biological function of these fimbriae is to facilitate bacterial adhesion to host tissues via specialized receptor-ligand interactions mediated by adhesin proteins at the fimbrial tips[2][5]. This adhesive capacity enables colonization, biofilm development, and immune evasion, contributing to diseases such as pneumonia, urinary tract infections, and liver abscesses[1][2][4]. Type 2 fimbriae are less well characterized but follow similar structural and functional principles[3]. Neither type is a receptor, enzyme, or transporter; they represent a unique class of virulence-related cellular appendages.
Inhibition of fimbrial-mediated adhesion (anti-adhesion therapy); Disruption of biofilm structure, impairing bacterial persistence.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fimbriae type 2 and type 3 (None established; occasionally "Type 2 fimbriae" or "Type 3 fimbriae" abbreviated in literature as "T2F" and "T3F," but not standardized.).